iSpecimen
ISPC
ISPC
12 hedge funds and large institutions have $239K invested in iSpecimen in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
60% less capital invested
Capital invested by funds: $597K → $239K (-$358K)
Holders
12
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$14.1K | |
| 2 | +$10.5K | |
| 3 | +$8K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$149 |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$64 |
Top Sellers
| 1 | -$33.1K | |
| 2 | -$24.7K | |
| 3 | -$21K | |
| 4 |
Morgan Stanley
New York
|
-$11.4K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$7.63K |